Leo’s enthusiasm is infectious. His co-workers say morale has only improved since he joined the Kensington police service ...

Starting therapy helped me understand why it affected me so much. I went through my twenties and got all this success, things happened so fast, and I became the caretaker for my whole family.

Last year, both Juno Therapeutics and Kite Pharma announced that a small number of patients had died in their respective CAR T-cell therapy trials. Juno’s trial was halted, but Kite’s carried on. The ...

The AK-OTOF therapy remains in early-stage clinical testing, but the success in the first patient to receive it – an 11-year-old boy who was profoundly deaf, but whose hearing is now reported to ...

"Therefore, access to CAR T-cell therapy is an important limitation to the success of this approach in not only high-income countries but particularly in low-income and middle-income countries," they ...